Silencing hsp25/hsp27 Gene Expression Augments Proteasome Activity and Increases CD8+ T-Cell–Mediated Tumor Killing and Memory Responses
Cancer Prevention Research, Jan 2012; 5: 122 - 137.
[HSPB1
]
Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
Mol. Cancer Res., Jan 2012; 10: 133 - 142.
[SREBF1
]
Androgen Deprivation Causes Epithelial–Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Cancer Res., Jan 2012; 72: 527 - 536.
[AR
]
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling
J. Biol. Chem., Jan 2012; 287: 1198 - 1209.
[Cnr2
]
High Performance Transfection with TurboFectin 8.0
The ultimate in high efficiency and low toxicity!
TurboFectin 8.0 is a new generation of transfection reagent optimized for nucleic acid delivery into eukaryotic cells. Its proprietary formulation of lipid/histone blend is supplied in 80% alcohol. TurboFectin 8.0 is the recommended transfection reagent for delivery of TrueClone/TrueORF Clone (for over-expression) and HuSH-29 constructs (shRNA for expression knock-down) in many different cell types. TurboFectin 8.0 has also been optimized and is the preferred reverse transfection reagent in GFC-Transfection Arrays.
Wide spectrum: validated on > 100 cell lines and primary cell types (Click for list)
Recommended for shRNA-induced silencing (click for data).
Preferred reagent for reverse transfection assays (click for data).
Simplified use: Works well in media containing antibiotic and antimycotic agents. Suitable for serum-containing media; no requirement for media change
Affordability: One mL can be used for 300-500 transfections of 6-well plate cultures, < $0.50 per transfection.
